Holen Sie sich die Stockscreener-App
0.545
4.80%
-0.0275
Handel nachbörslich:
.45
-0.095
-17.43%
Vistagen Therapeutics Inc Aktie (VTGN) Neueste Nachrichten
Vistagen Therapeutics Inc (VTGN) Q3 2026 Earnings Call Highlight - GuruFocus
Earnings call transcript: VistaGen Therapeutics Q3 2026 highlights AI-driven trial analysis - Investing.com UK
VistaGen (VTGN) Q3 2026 Earnings Call Transcript - The Globe and Mail
VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Lags Revenue Estimates - Bitget
Vistagen (VTGN) Surpasses Revenue Expectations in Q3 - GuruFocus
Vistagen Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
R&D-driven loss at Vistagen (Nasdaq: VTGN) as PALISADE-4 Phase 3 advances - Stock Titan
Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update - ChartMill
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesVTGN - PR Newswire
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ... - Bluefield Daily Telegraph
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER - GlobeNewswire
The Gross Law Firm Notifies Vistagen Therapeutics, Inc. Investors of a Class Action Lawsuit and ... - Bluefield Daily Telegraph
The Gross Law Firm Notifies Vistagen Therapeutics, Inc. - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Vistagen - GlobeNewswire
Investors who lost money with shares of Vistagen Therapeutics, - openPR.com
VTGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 - The Malaysian Reserve
LEVI & KORSINSKY, LLP ANNOUNCES SECURITIES CLASS ACTION FILED AGAINST VISTAGEN THERAPEUTICS UNDER FEDERAL SECURITIES LAWS - PR Newswire
Earnings To Watch: Vistagen Therapeutics Inc (VTGN) Reports Q3 2026 Result - GuruFocus
Gap Down: Will Vistagen Therapeutics Inc outperform during market ralliesJuly 2025 Weekly Recap & Daily Momentum Trading Reports - baoquankhu1.vn
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) DEADLINE ALERT Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Vistagen Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics - TMX Newsfile
Bronstein, Gewirtz & Grossman LLC Urges Vistagen - GlobeNewswire
Vistagen Therapeutics Securities Litigation: When Clinical Optimism Meets Disclosure Duty - TipRanks
VistaGen’s PALISADE-3 trial fails primary endpoint in SAD - MSN
VistaGen Receives Nasdaq Notice on Minimum Bid Compliance - TipRanks
Vistagen Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
VTGN Investors Encouraged to Seek Lead Plaintiff Role in - GlobeNewswire
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
VTGN Investor Alert: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026 - PR Newswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionVTGN - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics - marketscreener.com
Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (NASDAQ: VTGN) - GlobeNewswire
Investors who lost money on Vistagen Therapeutics, Inc.(VTGN) should contact The Gross Law Firm about pending Class ActionVTGN - ChartMill
VTGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
March 16, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTGN - The Malaysian Reserve
VTGN INVESTOR ALERTLEVI & KORSINSKY, LLP ANNOUNCES CLASS ACTION OVER ALLEGED MISLEADING STATEMENTS ABOUT CLINICAL TRIAL PROGRESS - The Malaysian Reserve
VTGN CLASS ACTION ALERT: Robbins LLP Urges Vistagen Therapeutics, Inc. Stockholders to Reach Out for Information About the Securities Class Action Lawsuit - The Malaysian Reserve
VTGN CLASS ACTION ALERT: Robbins LLP Urges Vistagen Therapeutics - GuruFocus
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, - GlobeNewswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Vistagen - GlobeNewswire
Vistagen Faces Securities Litigation Investigation - Intellectia AI
Vistagen Faces Class Action Lawsuit Impacting Stock Price - intellectia.ai
VTGN INVESTOR ALERT -- LEVI & KORSINSKY, LLP ANNOUNCES CLASS ACTION OVER ALLEGED MISLEADING STATEMENTS ABOUT CLINICAL TRIAL PROGRESS - Sahm
Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026 - marketscreener.com
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lead Plaintiff Deadline of March 16, 2026 in the Vistagen - GlobeNewswire
2026-02-04 | VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:VTGN | Press Release - Stockhouse
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionVTGN - TMX Newsfile
Vistagen Therapeutics Class Action Notice - Intellectia AI
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit - Barchart.com
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, I - GuruFocus
Aug Swings: Will Vistagen Therapeutics Inc outperform during market ralliesEarnings Overview Report & AI Driven Stock Reports - baoquankhu1.vn
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen - GlobeNewswire
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):